Skip to main content
Equibles

UBS Group AG

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1610520 ZURICH, V8
Back to IDYA Full portfolio

Position in IDYA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$24,475,991
-$932,108 QoQ
Shares Held
656,721
-13.9% QoQ
Ownership
0.681%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 286 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. IDYA ranks #66 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in IDYA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,475,991 656,721
2026-03-31 $25,408,099 762,548
2025-12-31 $37,530,296 1,085,632
2025-09-30 $28,749,459 1,056,577
2025-06-30 $15,805,042 751,905
2025-03-31 $7,373,406 450,147
2024-12-31 $10,755,063 418,485
2024-09-30 $4,420,847 139,547
2024-06-30 $8,033,343 228,805
2024-03-31 $10,664,989 243,049
2023-12-31 $5,361,975 150,702
2023-09-30 $1,525,314 56,535
2023-06-30 $212,651 9,049
2023-03-31 $775,113 56,454
2022-12-31 $2,082,335 114,603
2022-09-30 $221,562 14,850
2022-06-30 $63,562 4,606
2022-03-31 $854,590 76,371
2021-12-31 $2,774,555 117,367
2021-09-30 $1,131,016 44,371
2021-06-30 $487,198 23,211
2021-03-31 $290,577 12,365
2020-12-31 $12,026 859
2020-09-30 $3,240 258
2020-06-30 $54,211 3,815
2020-03-31 $2,892 702